MY ACCOUNT | NEWSLETTER |

Forsyth County Sheriff, Attorney General Urged to Investigate Wake Forest for "Planned Animal Cruelty" Involving Monkeys


A national physicians group is asking the Forsyth County Sheriff and North Carolina Attorney General to stop Wake Forest University from committing animal cruelty in a course scheduled for next week involving small monkeys. In a formal animal cruelty complaint filed today, the nonprofit Physicians Committee for Responsible Medicine explained that the procedures are likely to cause pain, suffering, injury, and potentially death.

The Physicians Committee explained in its complaint that a whistleblower informed it that the course, scheduled for Aug. 4-7, will allow pediatricians in training and others to perform invasive procedures on young vervet monkeys weighing about 2-4 pounds. Among the most invasive procedures to be performed on the monkeys is intubation, in which trainees force a plastic tube through the animals’ nasal passages or mouths and into their windpipes. The Physicians Committee points out that intubation can cause bleeding, scarring, injury to the vocal cords, and even fatal complications. Other procedures include inserting thin tubes into the animals’ urethras—which can cause painful bladder infections and injuries to the urethra—and using a needle to insert a tube into the artery, which can cause bleeding, infection, and the forming of blood clots.

In a related letter sent July 24 to NIH Director Jay Bhattacharya, the group called the practice “unjustifiable and possibly illegal,” pointing out that the animals to be used are part of a colony of vervets that received more than $1 million in funding from the agency earlier this year. It requested that the NIH instruct Wake Forest to cancel the course and halt funding for the colony.

The letter to the NIH, signed by a Harvard-trained pediatrician and other physicians, points out that no other pediatrics programs in the United States or Canada use animals. The physicians write that they have “never heard of a single medical center using monkeys” for this type of training. In a corresponding letter to Wake Forest University School of Medicine Dean L. Ebony Boulware, MD, MPH, they urge her to cancel the upcoming course.

The letters to the NIH and Dean Boulware emphasize that most trainees to whom the course is offered never take part and that more than 200 pediatrics programs in the U.S. and Canada teach procedures with lifelike newborn simulators, which Wake Forest owns, and shadowing of senior physicians.

"I never harmed animals to become a pediatrician,” said Margaret Peppercorn, MD, FAAP, of Portsmouth, R.I., who signed the letter. “The NIH should stop this course before it happens and cancel funding for this monkey colony that is failing to benefit patients.”

In the letter, Dr. Peppercorn and others point out the NIH’s recent effort to prioritize human-based research methods and reduce the use of animals mean Wake Forest’s vervet colony “appears misaligned with the agency’s evolving priorities.” The physicians point to experiments conducted using the colony related to Alzheimer’s, aging, obesity, and metabolic diseases that failed to benefit patients and that could have been done in humans or with human-relevant methods. One experiment forced 30 female vervets through a maze—including a pregnant monkey who carried her infant during the test—only to conclude that older animals walked slower. A paper published about the experiment acknowledged that numerous human clinical studies have been conducted on the issue but dismissed those studies as “difficult and expensive.”


Source: www.pcrm.org

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top